Year: 2025

JUPITER, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) — Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life science, food and nutrition, and bioindustrial applications, diverse commercial applications, today announced a significant expansion of its collaboration with Fermbox Bio, a biotech research & manufacturing company developing and delivering sustainable bio-based products through precision fermentation and advanced biotechnology tools. This expanded partnership broadens the range of products, platforms, and commercial opportunities the companies will jointly deliver to market. Building on their longstanding relationship, this agreement enables Fermbox Bio to manufacture and commercialize...

Beijing, China, Dec. 17, 2025 (GLOBE NEWSWIRE) — Token Cat Limited (Nasdaq: TC) (the “Company” or “Token Cat”)Today announced that Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) (“AZI”), a leading enterprise in China’s automobile sales and aftersales services sector, has reached a preliminary consensus with the Company on a proposed equity investment and business cooperation. Pursuant to the proposed arrangement, AZI plans to subscribe for newly issued shares of Token Cat at a price of US$30 per share, with an intended total investment amount of approximately US$100 million. Under the proposed arrangement, AZI plans to subscribe for newly issued shares of Token Cat  at a price of US$30 per share, with an intended total investment amount of approximately US$100 million. According to the current preliminary framework, the...

TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX: WM, OTCQX: WLBMF) (“Wallbridge” or the “Company”) is pleased to announce its 2026 budget and plans for its fully-funded 2026 exploration and related technical studies program at its Fenelon, Martiniere, Grasset and Casault gold projects in northwestern Quebec. The Company plans to drill ~25,000 metres in 2026 across the Martiniere, Fenelon, Casault, and Grasset projects, which represents an increase of approximately 30% of drilling over 2025. “As we close out 2025, I am very optimistic about the year ahead, supported by a strong balance sheet and a clearly defined strategy,” said Brian Penny, CEO of Wallbridge. “Our focus remains on unlocking value from our earlier-stage projects while continuing to advance our flagship Fenelon project toward a future...

Excluding prior year self-insurance adjustments, organic growth, adjusted EPS and adjusted EBITDA exceed management expectationsFourth quarter revenue was a record $2.3 billion, an increase of 5.4% over the prior year, with organic growth of 4.8% contributing meaningfully to overall performance Net income for the quarter totaled $34.8 million, or $0.56 per diluted share, improving from a net loss of $(11.7) million, or $(0.19) per share, a year ago Adjusted diluted EPS was $0.88, which includes a $(0.26) impact from prior year self-insurance adjustments, versus $0.88 last year, which included a $(0.02) impact Adjusted EBITDA for the quarter was $124.2 million, which incorporates a $(22.2) million pre-tax impact from prior year self-insurance adjustments; this compares with $125.6 million last year, which included a $(2.4) million pre-tax...

Operational Highlights NovemberOccupancy reached 68%. Average Cabin Revenue (ACR) increased by more than 15% compared to November 2024. Total ticket revenue was in line with November last year.Booking Position 2025As of today, 72% of 2025 capacity is booked, representing about 96% of the full-year targeted occupancy. ACR is currently 20% above same time last year for the full year.Booking Position 202647% of 2026 capacity is booked, about 8% ahead of same time last year. We target 10-15% ACR growth across cabin categories for 2026, supporting continued revenue growth and EBITDA margin expansion.*The KPIs provided are sourced from the Company’s (unaudited) booking system. Consequently, there may be variations or minor discrepancies in absolute figures and periodization compared to the reported financial statements. Revenue...

Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37% WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced four new partner agreements that meaningfully expand the Company’s in-workflow point-of-care (POC) network, fortify its long-term competitive position, and increase total National Provider Identifier (NPI) reach. The newly executed agreements include:An exclusive, multi-year agreement with a high-demand e-prescribing (eRx) platform previously available only through a competitive network A new partnership that extends the Company’s presence into...